Bottom line: Palantir continues to benefit from investor activity that is pricing the future, not the current P/E ratio into ...

U.S. stock indexes are slipping following the latest discouraging signal on the U.S. economy. The S&P 500 fell 0.4% Tuesday, ...

Clients of BofA Securities last week bought cyclical stocks at the fastest pace in years, according to a weekly report from a ...

The latest meme stock mania may have faded, but retail investors are always looking out for the next short-squeeze. Data from ...

Asian equities had a strong day, led by Australia, South Korea, Taiwan, Thailand, and Vietnam, while India underperformed, as ...

Prudent pricing, exposure growth, solid retention, renewals, and improved digitalization are expected to help AIG, MFC, and ...

Berkshire Hathaway stock fell after profits declines from a year ago while Palantir rose ahead of earnings. Tesla pared ...

Global stocks rose for a second session on Tuesday and the U.S. dollar steadied as investors raised bets the Federal Reserve ...

Discover the five best-performing blue chip stocks of 2025 so far. See which stocks are driving returns for investors this ...

ASP Isotopes, a cutting edge player in nuclear and quantum materials, has surged an impressive 107% so far in 2025. The ...

Palantir rose after earnings blew past Wall Street estimates, while shares of Vertex Pharmaceuticals and Hims & Hers ...

Jay Hatfield, CEO and CIO at Infrastructure Capital Advisors, joins CNBC's 'Power Lunch' to discuss why he's neutral on the ...